1. Home
  2. LFVN

as 11-15-2024 4:00pm EST

$
-
-
.
-
-
+
$
-
.
-
-
+
-
.
-
-
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. It offers products such as Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skincare product; Axio energy drink mixes; and PhysIQ, a weight management system, as well as Canine Health, a companion pet supplement formulated to combat oxidative stress in dogs. Geographically, its products are sold in the regions of the United States, Japan, Hong Kong, Australia, Canada, Philippines, Mexico, Thailand, the United Kingdom, and the Netherlands.

Founded: N/A Country:
United States
United States
Employees: N/A City: LEHI
Market Cap: 127.0M IPO Year: N/A
Target Price: N/A AVG Volume (30 days): 121.1K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield:
1.16%
Dividend Payout Frequency: Quarterly
EPS: 0.32 EPS Growth: 59.77
52 Week Low/High: $5.05 - $15.15 Next Earning Date: 10-29-2024
Revenue: $196,014,000 Revenue Growth: -7.97%
Revenue Growth (this year): 4.36% Revenue Growth (next year): 3.85%

LFVN Daily Stock ML Predictions

Stock Insider Trading Activity of Lifevantage Corporation (Delaware) (LFVN)

Name Ticker Relationship Date Transaction AVG Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
Lewis Darwin LFVN Director Sep 17 '24 Buy $10.27 351 $3,618.39 108,336
Mauro Garry Paul LFVN Director Sep 3 '24 Buy $7.40 1,600 $11,848.00 77,667

Share on Social Networks: